Alerts will be sent to your verified email
Verify Email
PARMAX
|
Parmax Pharma
|
Ortin Global
|
Shamrock Indl. Co
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
24.13 % | 1.67 % | 0.0 |
|
5yr average Equity Multiplier
|
29.23 | 2.06 | 1.02 |
|
5yr Average Asset Turnover Ratio
|
1.05 | 0.28 | 0.0 |
|
5yr Avg Net Profit Margin
|
-11.29 % | -124.59 % | 0.0 |
|
Price to Book
|
0.0 | 8.47 | 10.25 |
|
P/E
|
0.0 | 0.0 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
-92.25 Days | 1016.26 Days | 0.0 |
|
Inventory Days
|
69.37 Days | 326.59 Days | 0.0 |
|
Days Receivable
|
20.01 Days | 1081.4 Days | 0.0 |
|
Days Payable
|
296.94 Days | 645.07 Days | 0.0 |
|
5yr Average Interest Coverage Ratio
|
-0.77 | -64.13 | 0.0 |
|
5yr Avg ROCE
|
-14.3 % | -34.49 % | -8.65 % |
|
5yr Avg Operating Profit Margin
|
2.43 % | -107.87 % | 0.0 |
|
5 yr average Debt to Equity
|
10.96 | 0.51 | 0.0 |
|
5yr CAGR Net Profit
|
n/a | n/a | -15.95 % |
|
5yr Average Return on Assets
|
-9.05 % | -25.0 % | -8.47 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
30.8 % | 1.23 % | 43.36 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -14.45 % | 0.38 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Parmax Pharma
|
Ortin Global
|
Shamrock Indl. Co
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|